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Summary  This  report  presents  the  case  of  a  54-year-old  female  with  Takotsubo  cardiomy-
opathy that  recurred  12  years  after  the  ﬁrst  episode.  The  coronary  angiography  at  the  ﬁrst
admission revealed  ergonovine-induced  coronary  vasoconstriction  in  the  left  coronary  artery,
and recurrence  recurred  after  the  interruption  of  vasodilator  therapy  to  prevent  vasospasm.  InVasospasm;
Calcium  channel
blocking  drugs;
Microcirculation
addition,  the  coronary  angiography  both  in  the  ﬁrst  and  second  event  demonstrated  coronary
slow ﬂow  phenomenon,  which  improved  after  the  intracoronary  administration  of  nicorandil.
These ﬁndings  indicate  that  coronary  microvascular  constriction  plays  an  important  role  in  the
pathophysiology  of  Takotsubo  cardiomyopathy.
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akotsubo  cardiomyopathy  [1],  which  is  also  referred  to
s  either  apical  ballooning  or  stress  cardiomyopathy,  is
haracterized  by  the  sudden  onset  of  chest  symptoms,
lectrocardiographic  changes  consistent  with  myocardial
schemia,  and  reversible  left  ventricular  dysfunction  with-
ut  substantial  coronary  stenosis.  Although  the  precise
tiologic  basis  of  this  syndrome  remains  unclear,  sev-
ral  pathophysiological  mechanisms  have  been  proposed,
uch  as  acute  multivessel  coronary  vasospasm,  endothelial
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unctional  abnormality,  microvascular  dysfunction,  and
atecholamine-mediated  cardiotoxicity  [2—5].
Microvascular  constriction  is  thought  to  be  the  main
eterminant  of  left  ventricular  wall  motion  abnormalities  in
he  syndrome;  however,  whether  microvascular  dysfunction
s  the  primary  cause  of  the  syndrome  or  an  only  secondary
henomenon  remains  unclear.  This  report  presents  a  case
f  recurrent  Takotsubo  cardiomyopathy  with  coronary  slow
ow  phenomenon  (CSFP)  after  an  interruption  of  vasodila-
or  treatment,  which  suggests  that  microvascular  spasm  may
hus  play  an  important  role  in  this  syndrome.
ase report 54-year-old  female  taking  betamethasone  0.5  mg/day  for
olymyalgia  rheumatica  was  referred  in  1997  because  of
udden  chest  pain.  The  chest  pain  had  been  relieved  shortly
 Published by Elsevier Ltd. All rights reserved.
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Figure  1  The  electrocardiogram  (A)  on  the  ﬁrst  admission  showed  mild  ST  elevation  with  inverted  T  wave  in  the  anterolateral
 (B).  
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vleads, and  the  T  wave  inversions  became  deeper  on  the  3rd  day
to that  on  the  ﬁrst  admission.
after  admission;  however,  her  electrocardiogram  showed  a
mild  ST  elevation  in  the  anterolateral  leads  with  inverted  T
wave  (Fig.  1A)  and  the  echocardiogram  demonstrated  left
ventricular  apical  ballooning.  These  ﬁndings  led  to  the  deci-
sion  to  perform  emergency  cardiac  catheterization,  which
revealed  left  ventricular  apical  ballooning  (Fig.  2)  and  no
organic  coronary  stenosis  (Fig.  3A).  However,  the  coronary
ﬂow  was  delayed  (Fig.  3B)  and  Table  1  shows  the  corrected
Thrombosis  In  Myocardial  Infarction  (TIMI)  frame  counts,
which  was  adjusted  to  30  frames/s  and  divided  by  1.7  for
the  left  anterior  descending  artery  [6].  Her  blood  pressure
was  140/80  mmHg,  and  her  heart  rate  was  82/min.  Her  elec-
trocardiogram  transiently  showed  deep  negative  T  waves
(Fig.  1B)  and  the  apical  ballooning  was  gradually  normalized
in  2  weeks.  Elective  cardiac  catheterization  was  performed
on  the  18th  day.  The  left  ventriculogram  was  almost  nor-
mal  and  coronary  angiography  revealed  ergonovine-induced
a
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iThe  electrocardiogram  on  the  second  admission  (C)  was  similar
iffuse  constriction  of  the  left  coronary  artery  (Fig.  3C).
he  coronary  ﬂow  initially  improved  in  comparison  to  that
t  the  time  of  admission;  however,  the  coronary  ﬂow  was
elayed  after  the  spasm  provocation  test  followed  by  the
ntracoronary  administration  of  isosorbide  dinitrate  (Fig.  3D;
able  1).  Biopsy  samples  from  the  right  ventricle  showed
ild  interstitial  myocardial  ﬁbrosis  and  edema  (Fig.  4).
hese  ﬁndings  indicated  that  coronary  microvascular  spasm
aused  the  reversible  apical  ballooning  in  this  case,  although
he  role  of  the  epicardial  spasm  was  unclear,  and  thus  dil-
iazem  and  isosorbide  dinitrate  were  prescribed  to  prevent
asospasm.
The  medications  prevented  her  from  experiencing  a  heart
ttack  for  12  years  after  the  event,  while  a  diagnosis  of
yslipidemia  led  to  the  administration  of  pravastatin.  One
f  her  relatives  died  in  2009,  and  her  medication  was
nterrupted.  She  was  transferred  to  the  hospital  because
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cigure  2  Left  ventriculography  both  at  the  ﬁrst  emergency  c
howed similar  shaped  apical  ballooning.
f  a  second  heart  attack  a  few  days  later.  Her  chest
ain  continued  and  the  physical  examination  ﬁndings  were
nremarkable.  Her  blood  pressure  and  heart  rate  were
26/84  mmHg  and  94  beats/min,  respectively.  The  white
lood  cell  count  increased  to  9.0  ×  109/L,  while  the  heart-
ype  fatty  acid-binding  protein  and  creatine  kinase  were  not
Table  1  Corrected  Thrombolysis  In  Myocardial  Infarction
frame counts  of  coronary  angiography.
LAD  LCX  RCA
First  admission
Emergency  45  37  81
Control  31  27  34
After spasm  provocation  41  32  63
Second admission
Control  62  58  140
Isosorbide  dinitrate 61  56  ND
Nicorandil  33  34  ND
LAD, left anterior descending artery; LCX, left circumﬂex artery;
RCA, right coronary artery; ND, not done.
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wc  catheterization  (First)  and  at  the  second  admission  (Second)
levated.  Chest  X-rays  did  not  show  pulmonary  congestion,
ardiomegaly,  or  aortectasis,  and  her  electrocardiogram
evealed  a  mild  ST  elevation  with  negative  T  wave  in
he  anterolateral  leads,  which  was  similar  to  that  at  the
rst  admission  (Fig.  1C).  The  echocardiogram  demonstrated
id  to  apical  segment  akinesis,  which  was  also  similar  to
he  apical  ballooning  observed  in  1997.  Emergency  coro-
ary  angiography  showed  no  organic  stenosis,  thrombus,  or
picardial  spasm;  however,  the  coronary  artery  ﬂow  was
everely  delayed  (Table  1;  Fig.  5A).  Although  the  admin-
stration  of  isosorbide  dinitrate  did  not  change  the  slow
ow,  the  intracoronary  injection  of  nicorandil  2  mg  improved
he  delayed  ﬂow  (Fig.  5B,  Table  1).  In  addition,  the  nico-
andil  relieved  her  chest  oppression.  Left  ventriculography
howed  apical  ballooning  with  a decreased  ejection  frac-
ion  of  46%  (Fig.  2).  Her  hemodynamics  remained  stable
uring  the  intracoronary  administration,  and  her  blood  pres-
ure  and  heart  rate  at  the  start  and  the  end  of  the  cardiac
atheterization  were  120/90  mmHg  and  122/77  mmHg,  and
3/min  and  93/min,  respectively.  The  oral  administration
f  diltiazem  and  nicorandil  were  started  immediately  to
revent  coronary  spasm.  The  creatine  kinase  remained
ithin  the  normal  range.  The  apical  ballooning  improved
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Figure  3  Coronary  angiography  at  the  ﬁrst  admission.  Emergent  coronary  angiography  demonstrated  no  organic  coronary  stenosis
in the  left  coronary  artery  (A)  and  the  right  coronary  artery.  However,  the  coronary  ﬂow  was  delayed  and  the  left  coronary  artery  was
not ﬁlled  to  the  distal  at  the  20th  frame  (B),  which  was  acquired  at  30  frames/s.  Elective  angiography  before  the  discharge  revealed
ergonovine-induced  diffuse  constriction  in  the  left  coronary  artery  (C).  The  coronary  ﬂow  was  delayed  after  the  intracoronary
the  ladministration  of  isosorbide  dinitrate,  and  the  distal  portion  of  
frame (D).within  3  days  and  the  ejection  fraction  increased  to  57%.
The  negative  T  waves  in  her  electrocardiogram  became
deeper  in  1  week  and  then  gradually  normalized  within
2  months.
Figure  4  A  biopsy  sample  from  the  right  ventricle  showed
mild interstitial  myocardial  ﬁbrosis  and  edema  without  contrac-
tion band  necrosis.
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ﬁeft  coronary  artery  was  not  ﬁlled  with  the  contrast  at  the  20th
iscussion
SFP  is  an  angiographic  ﬁnding  characterized  by  a  delayed
rogression  of  contrast  medium  in  an  epicardial  coronary
rtery  without  signiﬁcant  coronary  stenosis.  This  phe-
omenon  with  chest  pain  was  ﬁrst  reported  in  1972  [7].  The
verall  incidence  of  CSFP  is  0.9%  among  patients  undergoing
oronary  angiography  [8],  and  7—24%  in  patients  with  normal
oronary  angiograms  presenting  with  angina-like  chest  pain
9,10].  This  phenomenon  is  observed  in  35%  of  patients  with
uspected  acute  coronary  syndrome  [11]. CSFP  is  typically
ound  in  young  male  smokers  and  the  long-term  outcome
s  unclear.  However,  the  rate  of  clinical  recurrence  is  84%
12], and  a  case  of  serious  arrhythmia  and  sudden  cardiac
eath  has  been  reported  [13]. Several  mechanisms  have
een  proposed  for  CSFP  [14], and  although  the  pathophys-
ology  may  be  heterogeneous,  intense  vasoconstriction  of
esistant  coronary  arteries  is  thought  to  represent  the  major
echanism  of  angina  in  patients  with  CSFP  [15].
The  coronary  ﬂow  is  prolonged  in  almost  all  patientsith  Takotsubo  cardiomyopathy,  and  their  TIMI  frame  counts
ncrease  signiﬁcantly  in  all  3  major  coronary  arteries  in
apan  [16], and  also  in  Western  countries  [17—19]. This
nding  is  consistent  with  a  reduced  coronary  ﬂow  reserve
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Figure  5  Emergent  coronary  angiography  at  the  recurrence.  Control  angiography  showed  severely  delayed  coronary  ﬂow  and
the distal  portion  of  left  coronary  artery  was  not  visualized  at  the  20th  frame  (A),  which  was  acquired  at  15  frames/s.  The  distal
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ceft anterior  descending  artery  (arrows)  was  ﬁlled  with  the  co
icorandil (B).
20—22]  and  abnormal  myocardial  perfusion  [4].  Myocardial
ontrast  echocardiography  demonstrated  that  the  regional
all  motion  abnormality  and  the  perfusion  defect  in  the
cute  phase  temporarily  decrease  with  intravenous  infusion
f  adenosine,  promptly  returning  to  baseline  immedi-
tely  after  cessation  of  the  adenosine  [23]. In  addition,
nother  report  showed  an  elevated  index  of  microcircula-
ory  resistance  measured  using  a  coronary  pressure  wire
24]. Therefore,  the  contribution  of  coronary  microvascular
onstriction  in  the  pathophysiology  of  Takotsubo  cardiomy-
pathy  seems  to  be  obvious.  On  the  other  hand,  a  recent
tudy  demonstrated  that  intracoronary  administration  of
icorandil  improved  the  prolonged  frame  count  in  patients
ith  CSFP  [8].  Nicorandil  is  a  hybrid  molecule  containing  an
TP-sensitive  potassium  channel  opener  and  a  nitric  oxide
onor,  and  it  behaves  as  a  selective  dilator  of  resistance
essels  [25]. The  improvement  in  CSFP  suggested  that  the
resence  of  spasm  in  resistance  vessels  is  the  main  factor
n  the  pathogenesis  of  the  CSFP.  The  similar  improvement  of
he  increased  TIMI  frame  count  with  nicorandil  in  the  present
ase  supported  the  contribution  of  coronary  microvascular
pasm  also  in  Takotsubo  cardiomyopathy.
Ergonovine-induced  coronary  vasoconstriction  in  the  left
oronary  artery  and  the  recurrence  of  Takotsubo  cardiomy-
pathy  after  the  interruption  of  isosorbide  dinitrate  and  a
alcium-channel  blocker  treatment  might  therefore  indicate
hat  coronary  spasm  plays  an  important  role  in  recurrence.
ultivessel  epicardial  coronary  spasm  is  one  of  the  proposed
echanisms  of  Takotsubo  cardiomyopathy  [26]; however,
he  absence  of  spastic  occlusion  in  the  epicardial  coronary
rtery  during  ST  elevation  does  not  favor  that  hypothesis.
n  addition,  the  1.6—11.4%  rate  of  recurrence  of  Takotsubo
ardiomyopathy  [27—31]  is  relatively  small  in  comparison
o  that  of  spastic  angina  [32,33].  Moreover,  a  chronobio-
ogical  analysis  of  Takotsubo  cardiomyopathy  shows  a  lower
requency  of  onset  at  night,  whereas  epicardial  spasm  most
ften  occurs  from  midnight  to  early  morning  [34—36]. The
ow  recurrence  rate  and  the  different  circadian  variations
r
h
c
bt  at  the  20th  frame  after  the  intracoronary  administration  of
lso  indicate  the  low  probability  of  epicardial  coronary
pasm  as  the  mechanism  of  Takotsubo  cardiomyopathy.  On
he  other  hand,  the  clinical  implications  of  epicardial  coro-
ary  vasoconstriction,  which  was  provoked  in  the  present
atient,  have  not  yet  been  fully  elucidated,  but  are  related
o  epicardial  spasm  and  microvascular  dysfunction  [37,38].
oreover,  Sun  et  al.  demonstrated  that  coronary  microvas-
ular  spasm  contributed  to  myocardial  ischemia  in  patients
ith  epicardial  coronary  spasm  [39]. Therefore,  hyperre-
ctivity  in  the  epicardial  coronary  artery  and  that  in  the
icrovessel  can  be  coincident  in  some  patients,  and  the
athophysiology  may  be  identical.
It  remains  unclear  whether  microvascular  spasm  in  the
resent  patient  was  the  primary  cause  of  Takotsubo  car-
iomyopathy  and  the  vasodilator  therapy  prevented  a  heart
ttack,  or  a  secondary  phenomenon  to  catecholamine
xcess.  The  patient  had  not  suffered  from  chest  pain  except
or  the  two  attacks,  and  the  administration  of  nicorandil
mproved  chest  pain  and  coronary  slow  ﬂow,  and  thus  the
icrovascular  dysfunction  may  be  transient.  She  had  expe-
ienced  emotional  stress  prior  to  the  second  attack,  which
as  a  typical  onset  pattern  of  Takotsubo  cardiomyopathy.
herefore,  catecholamine-induced  myocardial  toxicity  was
 possible  pathogenic  mechanism  underlying  the  microvas-
ular  spasm,  although  the  serum  catecholamine  levels  were
ot  measured  in  this  patient.  However,  the  patient’s  nor-
al  blood  pressure  and  heart  rate  at  the  admission  and  the
ack  of  ﬁndings  of  contraction  band  necrosis  in  the  biop-
ied  myocardium  might  imply  that  catecholamine  has  only  a
inor  role  in  the  pathophysiology  of  the  disease.
There  is  no  consensus  concerning  the  chronic  manage-
ent  of  Takotsubo  cardiomyopathy.  Although  the  abnormal
atecholamine  dynamics  related  to  emotional  distress  indi-
ate  that  a  beta-adrenoreceptor  blockade  might  prevent  the
ecurrence  of  Takotsubo  cardiomyopathy,  several  reports
ave  so  far  failed  to  show  any  preventive  effect  of  prior
hronic  treatment  with  beta-blockers  [29,30,40],  and  beta-
lockers  might  even  worsen  the  condition  [27]. This  failure
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of  beta-blockers  to  prevent  coronary  microvascular  spasm
might  make  sense,  and  vasodilators  of  coronary  microcir-
culation,  like  calcium-channel  blockers  and  nicorandil,  may
therefore  be  potential  therapeutic  agents  to  investigate  in
future  trials.  The  potentiality  of  the  vasodilators  is  also
supported  by  the  recurrence  after  the  withdrawal  of  a
calcium-channel  blocker  and  the  improvement  of  coronary
slow  ﬂow  by  the  administration  of  nicorandil  in  the  present
case.
Takotsubo  cardiomyopathy  was  ﬁrst  described  in  Japan,
and  this  condition  was  widely  recognized.  Long-term  follow-
up  data  are  still  lacking,  and  thus  the  recurrence  with  a
similar  pattern  12  years  after  the  ﬁrst  episode  is  a  rare
case.  More  recurrent  cases  will  be  collected  within  the  next
decade,  and  comparison  between  the  episodes  and  assess-
ment  of  medications  could  therefore  be  a  key  to  better
understand  the  pathophysiology  of  this  disease.
Conclusions
This  report  presented  a  case  of  Takotsubo  cardiomyopathy,
in  which  the  interruption  of  vasodilator  therapy  may  have
led  to  recurrence  after  12  years.  The  CSFP  observed  both
in  the  events  and  the  improvement  with  nicorandil  sug-
gested  that  microvascular  spasm  played  an  important  role
in  this  case.  CSFP  is  not  uncommon  in  patients  with  Takot-
subo  cardiomyopathy  and  assessment  of  coronary  ﬂow  with
the  TIMI  frame  count  is  easy;  however,  little  attention  has
so  far  been  paid  to  this  phenomenon.  Further  investigations
and  the  accumulation  of  more  cases  with  the  TIMI  frame-
counting  method  could  therefore  help  to  elucidate  the  role
of  microvascular  constriction  in  Takotsubo  cardiomyopathy.
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